中信建投:龍光集團(3380.HK)銷售規模排名提升,融資渠道優質通暢,維持買入評級
著名券商中信建投發佈最新研報,維持龍光集團(03380.HK)買入的投資評級,目標價12.6港元。該券商指出,當前地產行業在政策回暖帶動下優質房企的估值修復已經開啟,龍光集團信用水平優質,土儲聚焦在大灣區和長三角,結算利潤可期,將持續受益估值修復行情。
中信建投認為,龍光集團2021年銷售表現強勁,全年實現權益銷售額1402億,同比增長16%。增速在TOP20排名第五,在TOP20民營房企中排名第二,表現亮眼。
該券商指出,2021年龍光集團公開市場拿地大灣區佔比41.5%、長三角佔比42.9%,繼續聚焦在基本面強勁的大灣區和長三角,可開發土儲貨值充裕,能保障未來銷售的穩步增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.